{"id":"W4389243235","doi":"10.1182/blood-2023-180829","title":"Systematic Literature Review and Meta-Analysis of Comparative Clinical Evidence Investigating Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) As First-Line Treatment for Transplant-Ineligible Newly Diagnosed Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Lenalidomide; Medicine; Daratumumab; Population; Internal medicine; Multiple myeloma; Bortezomib; Oncology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03393865,0.003409696,0.0164247,0.01052552,0.0009582511,0.00384604,0.003227894,0.0028564,0.01007504],"category_scores_gemma":[0.08096009,0.001998402,0.03742069,0.00988181,0.001125721,0.002827016,0.003094519,0.002449713,0.0008060671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00605365,"about_ca_system_score_gemma":0.01450511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007925364,"about_ca_topic_score_gemma":0.01888656,"domain_scores_codex":[0.962777,0.02055756,0.01028328,0.002928077,0.002767888,0.000686354],"domain_scores_gemma":[0.9652416,0.0240272,0.005893255,0.001618676,0.002806086,0.0004131441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001685142,0.00003465766,0.001409868,0.7485492,0.2351304,0.000107821,0.0001876379,0.0006032069,0.0001388791,0.0004559121,0.001596618,0.01010053],"study_design_scores_gemma":[0.002521698,0.0003415186,0.002947713,0.1631606,0.8204722,0.0001213123,0.0001275651,0.0003915065,0.000227719,0.001125647,0.008485633,0.00007689127],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01445738,0.9133039,0.00884595,0.001888455,0.001097786,0.04219674,0.01534136,0.0003248521,0.002543593],"genre_scores_gemma":[0.196295,0.5927838,0.03231721,0.004152795,0.0004311929,0.1613793,0.0104051,0.0001379805,0.00209756],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03393865,"threshold_uncertainty_score":0.1794869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2515202993386563,"score_gpt":0.4348747019190569,"score_spread":0.1833544025804005,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}